Akira Murakami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Akira Murakami has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Akio Kobori
Faculty of Molecular Chemistry and Engineering, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan
2 shared publications - Asako Yamayoshi
Department of Life Science and Technology, Institute of Science Tokyo, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-0026, Japan
2 shared publications Maiko Higuchi
Department of Biomolecular Engineering , Kyoto Institute of Technology , Kyoto, Japan
2 shared publications- Akio Kobori
Faculty of Molecular Chemistry and Engineering, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan
1 shared publication - Eishi Ashihara
Laboratory of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan
1 shared publication - Hiroki Yamanaka
Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
1 shared publication
Latest Publications
- Open Access
- 12 June 2020
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (6) , 545
Development of Antibody–Oligonucleotide Complexes for Targeting Exosomal MicroRNA
MicroRNAs in exosomes (exosomal miRNAs) are considered as significant targets for cancer therapy. Anti-miR oligonucleotides are often used for the functional inhibition of miRNAs; however, there are no studies regarding the regulation of exosomal miRNA functions. In this study, we attempted to develop a novel drug delivery system using anti-exosome antibody–anti-miR oligonucleotide complexes (ExomiR-Tracker) to hijack exosomes to carry anti-miR oligonucleotides inside exosome-recipient cells. We found that ExomiR-Tracker bound to the exosomes, and then the complexes were introduced into the recipient cells. We also found that anti-miR oligonucleotides introduced into the recipient cells can exhibit inhibitory effects on exosomal miRNA functions in vitro and in vivo. We believe that our strategy would be a promising one for targeting exosomal miRNAs.
- 12 June 2020
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (6) , 545
Open AccessDevelopment of Antibody–Oligonucleotide Complexes for Targeting Exosomal MicroRNA
MicroRNAs in exosomes (exosomal miRNAs) are considered as significant targets for cancer therapy. Anti-miR oligonucleotides are often used for the functional inhibition of miRNAs; however, there are no studies regarding the regulation of exosomal miRNA functions. In this study, we attempted to develop a novel drug delivery system using anti-exosome antibody–anti-miR oligonucleotide complexes (ExomiR-Tracker) to hijack exosomes to carry anti-miR oligonucleotides inside exosome-recipient cells. We found that ExomiR-Tracker bound to the exosomes, and then the complexes were introduced into the recipient cells. We also found that anti-miR oligonucleotides introduced into the recipient cells can exhibit inhibitory effects on exosomal miRNA functions in vitro and in vivo. We believe that our strategy would be a promising one for targeting exosomal miRNAs.
- 26 November 2007
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 26 (10-12) , 1659-1664
Homogeneous Fluorescence Assays for RNA Diagnosis by Pyrene-Conjugated 2′-O-Methyloligoribonucleotides
We developed a bispyrene-conjugated 2 ′-O-methyloligoribonucleotide as an RNA-specific RNA-probe. The probe hybridized with the complementary RNA, greatly enhancing fluorescence and discriminating RNA from DNA. The assay was carried out in homogeneous aqueous media without removing the unbound probe from the detection solution. This homogeneous fluorescence assay also discriminated mismatch sequences in the target RNA. These pyrene probes could possess high potential to detect RNA in biological specimens simply.
- 26 November 2007
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 26 (10-12) , 1659-1664
Homogeneous Fluorescence Assays for RNA Diagnosis by Pyrene-Conjugated 2′-O-Methyloligoribonucleotides
We developed a bispyrene-conjugated 2 ′-O-methyloligoribonucleotide as an RNA-specific RNA-probe. The probe hybridized with the complementary RNA, greatly enhancing fluorescence and discriminating RNA from DNA. The assay was carried out in homogeneous aqueous media without removing the unbound probe from the detection solution. This homogeneous fluorescence assay also discriminated mismatch sequences in the target RNA. These pyrene probes could possess high potential to detect RNA in biological specimens simply.
- 4 April 2007
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 26 (3) , 277-290
Selective Photo-Cross-Linking of 2′-O-Psoralen-Conjugated Oligonucleotide with Rnas Having Point Mutations
It has been reported that point mutations in genes are responsible for various cancers and the selective regulation of the gene expression is an important issue to develop a new type of anticancer drugs. In this report, we present a new type of antisense molecule that photo-cross-links to an oligoribonucleotide having a point mutation site in a sequence specific manner. 2'-O-psoralen-conjugated adenosine was synthesized in four steps from adenosine and introduced in the middle of an oligodeoxyribonucleotide (2'-Ps-oligo). Compared with 5'-O-psoralen-conjugated oligodeoxyribonucleotide (5'-Ps-oligo), which has a psoralen at the 5'-end, 2'-Ps-oligo more selectively photo-cross-linked to a pyrimidine base of the site of alteration from purine to pyrimidine in the oligoribonucleotide.
- 4 April 2007
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 26 (3) , 277-290
Selective Photo-Cross-Linking of 2′-O-Psoralen-Conjugated Oligonucleotide with Rnas Having Point Mutations
It has been reported that point mutations in genes are responsible for various cancers and the selective regulation of the gene expression is an important issue to develop a new type of anticancer drugs. In this report, we present a new type of antisense molecule that photo-cross-links to an oligoribonucleotide having a point mutation site in a sequence specific manner. 2'-O-psoralen-conjugated adenosine was synthesized in four steps from adenosine and introduced in the middle of an oligodeoxyribonucleotide (2'-Ps-oligo). Compared with 5'-O-psoralen-conjugated oligodeoxyribonucleotide (5'-Ps-oligo), which has a psoralen at the 5'-end, 2'-Ps-oligo more selectively photo-cross-linked to a pyrimidine base of the site of alteration from purine to pyrimidine in the oligoribonucleotide.
- 25 May 1990
- Published by Wiley in ChemInform
- Vol. 21 (18)
ChemInform Abstract: Reactions of Polyfluoro‐2‐alkynoic Acids with 1,2‐Ethanedithiol.
The reaction of the fluoroalkynoic acids (I) with ethane‐1,2‐dithiol (II) is performed under various reaction conditions.
- 25 May 1990
- Published by Wiley in ChemInform
- Vol. 21 (18)
ChemInform Abstract: Reactions of Polyfluoro‐2‐alkynoic Acids with 1,2‐Ethanedithiol.
The reaction of the fluoroalkynoic acids (I) with ethane‐1,2‐dithiol (II) is performed under various reaction conditions.